Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as noted in the metadata) on December 13, 2010. The report addresses revised fiscal year 2011 guidance for the Company and its food subsidiary, Apio, Inc.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the issuance of revised qualitative guidance regarding future performance.
Material Changes
The Company has issued revised guidance for fiscal year 2011 revenue and net income growth. This change is attributed to adverse weather conditions (cold and wet) that have negatively impacted produce sourcing and increased sourcing costs for both the broader produce industry and the Company's subsidiary.
Guidance, Outlook, and Risks
- Revised Guidance: Management has lowered expectations for fiscal year 2011 revenue and net income growth.
- Primary Risk Factor: Ongoing cold and wet weather continues to adversely impact the supply chain and cost structure.
- Management Commentary: The impact on sourcing and costs is described as continuing and adverse.
Investor Verification Checklist
- Verify the specific numerical targets for the revised fiscal year 2011 revenue and net income guidance in the attached press release (Exhibit 99.1).
- Confirm the extent of the weather-related impact on Apio, Inc.'s specific sourcing regions.
- Review the Company's historical performance during similar weather events to assess the severity of the current outlook.